{"id":544259,"date":"2021-05-21T19:30:01","date_gmt":"2021-05-21T19:30:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=544259"},"modified":"2021-05-21T19:30:01","modified_gmt":"2021-05-21T19:30:01","slug":"plaque-psoriasis-market-analysis-market-size-epidemiology-leading-companies-and-therapies-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/plaque-psoriasis-market-analysis-market-size-epidemiology-leading-companies-and-therapies-delveinsight_544259.html","title":{"rendered":"Plaque Psoriasis Market Analysis, Market Size, Epidemiology, Leading Companies And Therapies | DelveInsight"},"content":{"rendered":"
\"Plaque<\/a><\/p>\n
\n
DelveInsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
DelveInsight\u2019s \u201cPlaque Psoriasis \u2013 Market Insights, Epidemiology, and Market Forecast-2030\u201d report delivers an in-depth understanding of the Plaque Psoriasis, historical and forecasted epidemiology as well as the Plaque Psoriasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<\/div>\n

DelveInsight has launched a new report on “Plaque Psoriasis – Market Insights, Epidemiology, and Market Forecast-2030<\/strong>”.<\/p>\n

DelveInsight’s “Plaque Psoriasis – Market Insights, Epidemiology, and Market Forecast-2030<\/strong><\/a>” report delivers an in-depth understanding of the Plaque Psoriasis, historical and forecasted epidemiology as well as the  Plaque Psoriasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n

Some of the key facts of the Report:<\/strong><\/p>\n

    \n
  1. \n

    In the U.S. population, Psoriasis affects 0.6 to 4.8 per cent and about 30% of affected patients have a first-degree relative with the disease<\/p>\n<\/li>\n

  2. \n

    According to the Foundation, more than 8 million Americans have psoriasis. Plaque psoriasis is the most common form of the disease, affecting 80 per cent of those with psoriasis.<\/p>\n<\/li>\n

  3. \n

    In the U.S., the prevalence of Psoriasis is estimated to be 0.6 to 4.8%.<\/p>\n<\/li>\n

  4. \n

    125 million people worldwide which is about 2 to 3 per cent of the total population have psoriasis<\/p>\n<\/li>\n<\/ol>\n

    Key benefits of the report:<\/strong><\/p>\n

    1. Plaque Psoriasis market report covers a descriptive overview and comprehensive insight of the Plaque Psoriasis Epidemiology and Plaque Psoriasis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)<\/p>\n

    2. The Plaque Psoriasis market report provides insights on the current and emerging therapies.<\/p>\n

    3. Plaque Psoriasis market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/p>\n

    4. The Plaque Psoriasis market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Plaque Psoriasis market.<\/p>\n

    Request for sample pages: https:\/\/www.delveinsight.com\/sample-request\/plaque-psoriasis-market<\/span><\/a>
    <\/a><\/strong><\/p>\n

    Plaque Psoriasis: Overview<\/strong><\/p>\n

    Psoriasis is a common skin condition that speeds up the life cycle of skin cells. It causes cells to build up rapidly on the surface of the skin. The extra skin cells form scales and red patches that are itchy and sometimes painful.<\/p>\n

    The key players involved in the Plaque Psoriasis market<\/a>:<\/strong><\/p>\n

      \n
    1. \n

      Bristol-Myers Squibb, <\/p>\n<\/li>\n

    2. \n

      Dermavant Sciences GmbH, <\/p>\n<\/li>\n

    3. \n

      Arcutis, Inc., <\/p>\n<\/li>\n

    4. \n

      Avillion LLP <\/p>\n<\/li>\n<\/ol>\n

      The launch of the emerging therapies is expected to significantly impact the  Plaque Psoriasis treatment scenario in the upcoming years:-<\/strong><\/p>\n

      Drug covered<\/strong><\/p>\n

        \n
      1. \n

        BMS-986165<\/p>\n<\/li>\n

      2. \n

        Tapinarof<\/p>\n<\/li>\n

      3. \n

        ARQ-151<\/p>\n<\/li>\n

      4. \n

        M1095<\/p>\n<\/li>\n<\/ol>\n

        Request a free sample report @https:\/\/www.delveinsight.com\/sample-request\/plaque-psoriasis-market<\/span><\/a><\/strong><\/p>\n

        Table of Contents<\/strong><\/p>\n

        1. Report Introduction<\/p>\n

        2. Executive Summary<\/p>\n

        3. SWOT analysis<\/p>\n

        4. Plaque Psoriasis Patient Share (%) Overview at a Glance<\/p>\n

        5. Plaque Psoriasis Market Overview at a Glance<\/p>\n

        6. Plaque Psoriasis Disease Background and Overview<\/p>\n

        7. Plaque Psoriasis Epidemiology and Patient Population<\/p>\n

        8. Country-Specific Patient Population of Plaque Psoriasis<\/p>\n

        9. Plaque Psoriasis Current Treatment and Medical Practices<\/p>\n

        10. Unmet Needs<\/p>\n

        11. Plaque Psoriasis Emerging Therapies<\/p>\n

        12. Plaque Psoriasis Market Outlook<\/p>\n

        13. Country-Wise Plaque Psoriasis Market Analysis (2017–2030)<\/p>\n

        14. Market Access and Reimbursement of Therapies<\/p>\n

        15. Market drivers<\/p>\n

        16. Market barriers<\/p>\n

        17. Appendix<\/p>\n

        18. Plaque Psoriasis Report Methodology<\/p>\n

        19. DelveInsight Capabilities<\/p>\n

        20. Disclaimer<\/p>\n

        21. About DelveInsight<\/p>\n

        Related Reports:<\/strong><\/p>\n

        Plaque Psoriasis – Pipeline Insights, 2021<\/strong><\/p>\n

        “Plaque Psoriasis Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Plaque Psoriasis market. A detailed picture of the Plaque Psoriasis pipeline landscape is provided, which includes the disease overview and  Plaque Psoriasis treatment guidelines.<\/p>\n

        Plaque Psoriasis – Epidemiology Forecast to 2030<\/strong><\/p>\n

        DelveInsight’s ‘Plaque Psoriasis- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Plaque Psoriasis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/p>\n

        Media Contact<\/span>
        Company Name:<\/strong>         DelveInsight Business Research LLP<\/a>
        Contact Person:<\/strong> Kritika Rehani
        Email:<\/strong>         Send Email<\/a>
        Phone:<\/strong> 9193216187
        Address:<\/strong>304 S. Jones Blvd #2432
        City:<\/strong> Las Vegas
        State:<\/strong> Nevada
        Country:<\/strong> United States
        Website:<\/strong>         https:\/\/www.delveinsight.com\/<\/a><\/p>\n

        <\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

        DelveInsight Business Research LLP DelveInsight\u2019s \u201cPlaque Psoriasis \u2013 Market Insights, Epidemiology, and Market Forecast-2030\u201d report delivers an in-depth understanding of the Plaque Psoriasis, historical and forecasted epidemiology as well as the Plaque Psoriasis market trends in the United States, EU5 … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-544259","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/544259","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=544259"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/544259\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=544259"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=544259"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=544259"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}